首页|小潮气量机械通气和人免疫球蛋白联合治疗儿童重症肺炎疗效观察

小潮气量机械通气和人免疫球蛋白联合治疗儿童重症肺炎疗效观察

Clinical efficacy of low tidal volume mechanical ventilation combined with human immunoglobulin in the treatment of severe pneumonia in children

扫码查看
目的 探讨小潮气量机械通气联合人免疫球蛋白治疗儿童重症肺炎的临床疗效及对患儿肺功能、体液免疫功能的影响.方法 选择2019年1月至2020年12月驻马店市中心医院收治的126例重症肺炎患儿为研究对象.根据治疗方法将患儿分为对照组(n=65)和观察组(n=61).2组患儿均给予常规治疗,在此基础上,对照组患儿给予小潮气量机械通气治疗,观察组患儿给予小潮气量机械通气联合人免疫球蛋白治疗,2组患儿均连续治疗1周.比较2组患儿的临床疗效、治疗前后肺功能指标[第1秒用力呼气量(FEV1)、用力肺活量(FVC)、呼气流量峰值(PEF)]、血气分析指标[动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、氧合指数(PaO2/FiO2)]、体液免疫功能指标[免疫球蛋白(Ig)A、IgG、IgM]及不良反应发生情况.结果 对照组和观察组患儿治疗总有效率分别为73.85%(48/65)、88.52%(54/61),观察组患儿总有效率显著高于对照组(P<0.05).治疗前2组患儿FEV1、FVC、PEF比较差异无统计学意义(P>0.05);2组患儿治疗后FEV1、FVC、PEF均显著高于治疗前(P<0.05);治疗后,观察组患儿FEV1、FVC、PEF均显著高于对照组(P<0.05).治疗前2组患儿PaO2、PaCO2、PaO2/FiO2比较差异无统计学意义(P>0.05);2组患儿治疗后PaO2、PaO2/FiO2显著高于治疗前,PaCO2显著低于治疗前(P<0.05);治疗后,观察组患儿PaO2、PaO2/FiO2显著高于对照组,PaCO2显著低于对照组(P<0.05).治疗前2组患儿IgA、IgG、IgM水平比较差异无统计学意义(P>0.05);2组患儿治疗后IgA、IgG、IgM水平显著低于治疗前(P<0.05);治疗后,观察组患儿IgA、IgG、IgM水平显著低于对照组(P<0.05).对照组和观察组患儿不良反应发生率分别为18.46%(12/65)、32.79%(20/61),2组患儿不良反应发生率比较差异无统计学意义(x2=0.007,P>0.05).结论 相较于小潮气量机械通气治疗,小潮气量机械通气联合人免疫球蛋白治疗儿童重症肺炎临床疗效更显著,能有效改善患儿肺功能、血气分析指标及体液免疫功能,且不会明显增加不良反应.
Objective To investigate the clinical efficacy of low tidal volume mechanical ventilation combined with human immunoglobulin in the treatment of severe pneumonia in children and the effects on lung function and humoral immune function.Methods A total of 126 children with severe pneumonia admitted to the Zhumadian Central Hospital from January 2019 to December 2020 were selected as the research subjects.According to the treatment method,the children were divided into a control group(n=65)and an observation group(n=61).All children in the two groups were given routine treatment.On this basis,children in the control group were given low tidal volume mechanical ventilation,while children in the observation group were given low tidal volume mechanical ventilation combined with human immunoglobulin.All children in the two groups were treated continuously for 1 week.The clinical efficacy,pulmonary function indexes[forced expiratory volume in one second(FEV1),forced vital capacity(FVC),and peak expiratory flow(PEF)]before and after treatment,blood gas analysis indexes[arterial partial pressure of oxygen(PaO2),arterial partial pressure of carbon dioxide(PaCO2),and oxygenation index(PaO2/FiO2)],humoral immune function indexes[immunoglobulin(Ig)A,IgG,and IgM],and the occurrence of adverse reactions were compared between the two groups.Results The total effective rates of children in the control group and the observation group were 73.85%(48/65)and 88.52%(54/61),respectively,and the total effective rate of children in the observation group was significantly higher than that in the control group(P<0.05).There was no significant difference in FEV1,FVC and PEF between the two groups before treatment(P>0.05).After treatment,FEV1,FVC and PEF of children in the two groups were significantly higher than those before treatment(P<0.05).After treatment,FEV1,FVC and PEF of children in the observation group were significantly higher than those in the control group(P<0.05).There was no significant difference in PaO2,PaCO2,and PaO2/FiO2 between the two groups before treatment(P>0.05).After treatment,PaO2 and PaO2/FiO2of children in the two groups were significantly higher than those before treatment,while PaCO2 was significantly lower than that before treatment(P<0.05).After treatment,PaO2 and PaO2/FiO2of children in the observation group were significantly higher than those in the control group,while PaCO2 was significantly lower than that in the control group(P<0.05).There was no significant difference in IgA,IgG and IgM levels between the two groups before treatment(P>0.05).After treatment,the IgA,IgG and IgM levels of children in the two groups were significantly lower than those before treatment(P<0.05).After treatment,the IgA,IgG and IgM levels of children in the observation group were significantly lower than those in the control group(P<0.05).The incidence of adverse reactions in the control group and the observation group was 18.46%(12/65)and 32.79%(20/61),respectively.There was no significant difference in the incidence of adverse reactions between the two groups(x2=0.007,P>0.05).Conclusion Compared with low tidal volume mechanical ventilation,low tidal volume mechanical ventilation combined with human immunoglobulin has more significant clinical efficacy in the treatment of children with severe pneumonia,which can effectively improve lung function,blood gas analysis indexes and humoral immune function of children and will not significantly increase adverse reactions.

severe pneumoniasmall tidal volume mechanical ventilationhuman immunoglobulinlung functionhu-moral immunitychildren

王春雨、李亚、王家豪

展开 >

驻马店市中心医院急诊儿科,河南 驻马店 463000

重症肺炎 小潮气量机械通气 人免疫球蛋白 肺功能 体液免疫 儿童

2024

新乡医学院学报
新乡医学院

新乡医学院学报

CSTPCD
影响因子:0.999
ISSN:1004-7239
年,卷(期):2024.41(10)
  • 10